Zostavax Uses

Links shared publicly online about this topic

FDA Expands Indication for Zostavax, Merck's Shingles Vaccine, to Include Adults Ages 50 to 59

drugs.com — “Zostavax (zoster vaccine live) is used for prevention of herpes zoster. Information from Drugs.com includes Zostavax side effects, interactions and indications.View full resource at drugs.com

  • View Related
  • Share

Most Recently Shared on March 26, 2011 at 7:13 pm By:

Drugs_Devices Drugs and Devices OW OW Health

FDA Expands Indication for Zostavax, Merck's Shingles Vaccine, to Include Adults Ages 50 to 59: WHITEHOUSE... http://bit.ly/eEOmdE #drug

1 year ago...

FDA Expands Indication for Zostavax, Merck's Shingles Vaccine, to Include Adults Ages 50 to 59

drugs.com — “Zostavax (zoster vaccine live) is used for prevention of herpes zoster. Information from Drugs.com includes Zostavax side effects, interactions and indications.View full resource at drugs.com

  • View Related
  • Share

Most Recently Shared on March 27, 2011 at 9:00 pm By:

drugscom Drugs.com Health Site

FDA Expands Indication for Zostavax, Merck's Shingles Vaccine, to Include Adults Ages 50 to 59 - http://bit.ly/eY0eWo

1 year ago...

Zostavax Approved For People Ages 50 To 59 : Shots - Health Blog : NPR

npr.org — “Zostavax, a vaccine against shingles, is now approved for people 50 to 59 years old. The vaccine, given in a single shot, was previously for use in people 60 years and older.View full resource at npr.org

  • View Related
  • Share

Most Recently Shared on March 25, 2011 at 1:59 pm By:

Zostavax Approved For People Ages 50 To 59 : Shots - Health Blog : NPR

npr.org — “Zostavax, a vaccine against shingles, is now approved for people 50 to 59 years old. The vaccine, given in a single shot, was previously for use in people 60 years and older.View full resource at npr.org

  • View Related
  • Share

Most Recently Shared on March 27, 2011 at 1:46 am By:

Zostavax Approved For People Ages 50 To 59 : Shots - Health Blog : NPR

npr.org — “Zostavax, a vaccine against shingles, is now approved for people 50 to 59 years old. The vaccine, given in a single shot, was previously for use in people 60 years and older.View full resource at npr.org

  • View Related
  • Share

Most Recently Shared on March 25, 2011 at 3:14 pm By:

gehealthy Healthymagination Health Site

FDA has approved a shingles vaccine for broader use, giving treatment to a greater range of patients: http://su.pr/2tdv69 #healthymagination

1 year ago...

RxEconsult, LLC - Zostavax (Zoster Vaccine Live) for preventing shingles (herpes zoster)

rxeconsult.com — “RxEconsult, LLC - Zostavax (Zoster Vaccine Live) for preventing shingles (herpes zoster)View full resource at rxeconsult.com

  • View Related
  • Share

Most Recently Shared on September 20, 2011 at 12:20 pm By:

RxEconsultRxEconsult. If you are in need of healthcare services or information, please visit RxEconsult. 

Dr. Ogbru received his Doctorate in Pharmacy from the University of the Pacific School of Pharmacy in 1995. He completed a Pharmacy Practice Residency at the University of Arizona/University Medical Center in 1996. He was a Professor of Pharmacy Practice and a Regional Clerkship Coordinator for the University of the Pacific School of Pharmacy from 1996-99.

Dr. Ogbru has written several journal articles. In 1997, he shared an award from the American Journal of Pain Management for Outstanding Contribution to the Interdisciplinary Pain Management Literature. Over the last 12 years Dr. Ogbru has held several roles in the pharmaceutical industry, including Director of Global Medical Information and Communication." /> Ome Ogbru, PharmD Active Health Library, Doctor, Pharmacist, and PharmD

In Investigational Study, Zostavax, Merck's Shingles Vaccine, Reduced Incidence of Shingles in Adults Ages 50 to 59 by Nearly 70 Percent - Drugs.com MedNews

drugs.com — “Merck filed application for use in this age group earlier this year Oct 21, 2010 - In a large clinical study of adults ages 50 to 59, ZOSTAVAX (Zoster Vaccine LView full resource at drugs.com

  • View Related
  • Share

Most Recently Shared on October 21, 2010 at 10:05 pm By:

Drugs_Devices Drugs and Devices OW OW Health

In Investigational Study, Zostavax, Merck's Shingles Vaccine, Reduced Incidence of Shingles in Adults Ages 50... http://bit.ly/aOaAC6 #drug

2 years ago...

Health News - FDA Approves Expanded Use of Shingles Vaccine

healthnews.com — “The U.S. Food and Drug Administration (FDA) has now approved use of the varicella-zoster vaccine, Zostavax, among patients ages 50 to 59 for the prevention of herpes zoster, more commonly known as shingles. Until now, use of the vaccine had only been sanctioned for use in people aged 60 or older.View full resource at healthnews.com

  • View Related
  • Share

Most Recently Shared on March 25, 2011 at 4:15 pm By:

HealthNewsUS Susan Brady Health News

FDA Approves Expanded Use of Shingles Vaccine http://ht.ly/4mpYC

1 year ago...

U.S. Shingles Vaccine Approval Expanded - Drugs.com MedNews

drugs.com — “The Zostavax shingles vaccine is now approved by the U.S. Food and Drug Administration for people aged 50 and older. FDA-sanctioned use of the vaccine, first apView full resource at drugs.com

  • View Related
  • Share

Most Recently Shared on March 24, 2011 at 10:10 pm By:

Drugs_Devices Drugs and Devices OW OW Health

U.S. Shingles Vaccine Approval Expanded: THURSDAY, March 24 -- The Zostavax shingles vaccine is now approv... http://bit.ly/hXdxHo #drug

1 year ago...

Merck shingles vaccine effective in adults in 50s | Reuters

reuters.com — “NEW YORK (Reuters) - In a huge study aimed at broadening the use of Merck & Co's shingles vaccine, Zostavax reduced the incidence of the painful disease by 70 percent compared with a placebo in adultsView full resource at reuters.com

  • View Related
  • Share

Most Recently Shared on October 21, 2010 at 4:30 am By:

Reuters_Health Reuters Health Health News

Merck shingles vaccine effective in adults in 50s http://dlvr.it/7JvG9

2 years ago...

Merck shingles vaccine effective in adults in 50s | Reuters

reuters.com — “NEW YORK (Reuters) - In a huge study aimed at broadening the use of Merck & Co's shingles vaccine, Zostavax reduced the incidence of the painful disease by 70 percent compared with a placebo in adultsView full resource at reuters.com

  • View Related
  • Share

Most Recently Shared on October 21, 2010 at 7:45 am By:

hrana Hisham Rana, MD Doctor and Physician

Research: Merck shingles vaccine effective in adults in 50s http://reut.rs/aIQ4BM - To be presented at the IDSA meeting on Saturday. #health

2 years ago...

Medical News: FDA Okays Shingles Vaccine for Younger Age Group - in Public Health & Policy, FDA General from MedPage Today

medpagetoday.com — “WASHINGTON -- The FDA has approved use of the varicella zoster vaccine Zostavax in patients ages 50 to 59.View full resource at medpagetoday.com

  • View Related
  • Share

Most Recently Shared on March 24, 2011 at 10:00 pm By:

MedicalNews Medical News Health News

FDA Okays Shingles Vaccine for Younger Age Group http://bit.ly/gk5XYJ

1 year ago...

Medical News: FDA Okays Shingles Vaccine for Younger Age Group - in Public Health & Policy, FDA General from MedPage Today

medpagetoday.com — “WASHINGTON -- The FDA has approved use of the varicella zoster vaccine Zostavax in patients ages 50 to 59.View full resource at medpagetoday.com

  • View Related
  • Share

Most Recently Shared on March 24, 2011 at 9:59 pm By:

MedicalFeed MedicalFeed Health News Feed

FDA Okays Shingles Vaccine for Younger Age Group: WASHINGTON (MedPage Today) -- The FDA has… http://goo.gl/fb/Qvr8B

1 year ago...

Medical News: Shingles Vaccine Holds Up in Clinic, but Underused - in Primary Care, Vaccines from MedPage Today

medpagetoday.com — “The herpes zoster vaccine (Zostavax) effectively reduces shingles risk in real-world use, but few older adults are getting immunized, two separate studies showed.View full resource at medpagetoday.com

  • View Related
  • Share

Most Recently Shared on January 11, 2011 at 10:33 pm By:

MedicalNews Medical News Health News

Shingles Vaccine Holds Up in Clinic, but Underused (CME/CE, with video) http://bit.ly/gQrbqx

1 year ago...

Shingles Vaccine Holds Up in Clinic, but Underused (CME/CE, with video) - QualityPoint Technologies

qualitypointtech.net — “(MedPage Today) -- The herpes zoster vaccine (Zostavax) effectively reduces shingles risk in real-world use, but few older adults are getting immunized, two separate studies showed.View full resource at qualitypointtech.net

  • View Related
  • Share

Most Recently Shared on January 11, 2011 at 11:01 pm By:

MedicalFeed MedicalFeed Health News Feed

Shingles Vaccine Holds Up in Clinic, but Underused (CME/CE, with video): (MedPage Today) -- The herpes zoster vacc... http://bit.ly/f71hpG

1 year ago...

The Top 3 resources shared on this topic. More resources.

Key stats and trends about this topic

Featuring the top 3 experts for this topic

  • Drugs_Devices

    Drugs and Devices OW

    Organizing drug and medical device resources shared by health experts, advocates, and organizations into WisdomCards.

    View Profile

  • drugscom

    Drugs.com

    Keeping you up to date with the latest medication news, FDA Medwatch alerts and new drug approvals.

    View Profile

  • SermoTeam

    Sermo Team

    Sermo is where 120,000 physicians collaborate on difficult cases, exchange clinical insights and build consensus on drugs, devices and treatment options.

    View Profile

Advertisement

Share via Email

Share this WisdomCard with others by embedding on your site or blog.

300x260

425x300

560x390